Skip to main content

Table 1 Survival rate after neoadjuvant radio-chemotherapy for locally advanced adenocarcinoma

From: The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract

Study

Adeno-carcinoma n (%)

Survival RTX

Survival Surgery

p-value

Walsh et al. 1996 [7]

113 (100%)

32% (3 y)

6% (3 y)

0.01

Urba et al. 2001 [43]

75 (75%)

30% (3 y)

16% (3 y)

0.15

Burmeister et al. 2005 [44]

158 (62%)

28% (3 y)

30% (3 y)

0.81

Tepper et al. 2008 [45]

42 (75%)

39% (5 y)

16% (5 y)

0.002

Stahl et al. 2009 [8]

119 (100%)

47.7% (3 y)

27.4%

0.07

   

(CHX, 3 y)

 
  1. RTX = radio-chemotherapy, CHX = chemotherapy, y = years